Tekla Life Sciences Investors (HQL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Tekla Life Sciences Investors, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 5.23x | 4.96x | 15.78x | -3.35x | 7.82x | 3.41x |
| P/B Ratio | 0.87x | 0.92x | 0.88x | 0.88x | 0.96x | 0.87x |
| P/S Ratio | 5.18x | 4.88x | 8.96x | 11.01x | 11.21x | 10.73x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 46.4% | 82.6% | 86.5% | 86.7% |
| Operating Margin | 99.1% | 98.4% | -13.3% | -328.3% | 143.3% | 314.9% |
| Net Margin | 99.1% | 98.4% | 56.8% | -328.3% | 143.3% | 314.9% |
| EBITDA Margin | 99.1% | 100.6% | 126.8% | -318.9% | 152.5% | 315.0% |
| Liquidity | ||||||
| Current Ratio | 1.74x | 0.32x | 0.00x | 0.12x | 0.01x | 0.13x |
| Quick Ratio | 1.74x | 0.32x | 0.00x | 0.12x | 0.01x | 0.13x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.03x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..